Mote P, Gompel A, Howe C, Hilton H, Sestak I, Cuzick J, et al. Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial. Breast Cancer Res Treat. 2015;151:309-18 pubmed publisher

Trippel M, Imboden S, Papadia A, Mueller M, Mertineit N, Härmä K, et al. Intestinal differentiated mucinous adenocarcinoma of the endometrium with sporadic MSI high status: a case report. Diagn Pathol. 2017;12:39 pubmed publisher

Tapia Pizarro A, Figueroa P, Brito J, Marín J, Munroe D, Croxatto H. Endometrial gene expression reveals compromised progesterone signaling in women refractory to embryo implantation. Reprod Biol Endocrinol. 2014;12:92 pubmed publisher

Chung K, Hovanessian Larsen L, Hawes D, Taylor D, Downey S, Spicer D, et al. Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation. Breast Cancer Res Treat. 2012;132:653-60 pubmed publisher

Mc Cormack O, Chung W, Fitzpatrick P, Cooke F, Flynn B, Harrison M, et al. Growth arrest-specific gene 6 expression in human breast cancer. Br J Cancer. 2008;98:1141-6 pubmed publisher